On 2/29/24, ANI Pharmaceuticals Inc (NASDAQ: ANIP) stock enjoyed a major increase of 12.3%, closing at $67.67. Moreover, trading volume in this advance was exceptionally high at 697% of normal. The stock has been strong relative to the market over the last nine months and has risen 17.4% during the last week.
Current PriceTarget Research Rating
ANIP’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
ANI Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. ANI Pharmaceuticals has a poor Appreciation Score of 29 but a slightly positive Power Rating of 66, resulting in the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment